Clinical Performance of Serafilcon A Weekly Replacement Contact Lenses in Satisfied Comfilcon A Monthly Lens Wearers: A Prospective Study.
Trone Marie-Caroline MC, Alroumi Hala H, Some Stéphanie S, Ollier Edouard E
Contact lens discomfort remains a leading cause of discontinuation, particularly for patients seeking more affordable alternatives to daily disposable lenses. This study evaluated subjective comfort, vision, and objective ocular surface parameters in satisfied Comfilcon A (monthly) wearers after switching to Serafilcon A (weekly) lenses, which incorporate a wetting-system technology designed to optimize tear film stability. This prospective, single-center, non-comparative study enrolled 30 participants (20-40 years) satisfied with Comfilcon A (VAS score ≥70/100 for comfort and vision). Two were screen failures and one was lost to follow-up, leaving 27 completers. After 14 ± 2 days of Serafilcon A wear, participants completed the Contact Lens Dry Eye Questionnaire-8 (CLDEQ-8), rated comfort and vision on a Visual Analog Scale (VAS, 0-100; 0 = poor, 100 = excellent), and underwent C.DIAG ocular surface assessment. No adverse events occurred. Analyses were descriptive; no baseline ocular surface data were available. The primary endpoint (VAS comfort >75/100) was met by 85.2% of participants (23/27; mean 88.5 ± 13.3). Mean vision VAS was 88.0 ± 16.7, and mean CLDEQ-8 score was 9.8 ± 7.1 (51.9% Excellent/Very Good; 22.2% Unsatisfied). Mean VAS for likelihood to continue wearing was 65.4 ± 39.5; 70.4% were Very Likely to recommend the lenses (5-point Likert scale). Best-corrected visual acuity was 20/20 for all participants. C.DIAG measurements were within previously reported ranges for lens wearers: break-up time 6.49-6.64 s, interferometry 74.9-80.6 nm, tear meniscus height 0.22-0.24 mm (right/left eye). In this single-arm, two-week study, satisfied Comfilcon A wearers refitted with Serafilcon A reported high comfort and vision, with C.DIAG parameters in the expected range for short-term lens wear. These findings support short-term acceptability of Serafilcon A among patients already satisfied with monthly lenses; longer-term and comparative studies are needed before claims of cost-effectiveness or superiority can be made.